A 5-SKU cosmeceutical skincare packaging design, built on the Jarsking oblong capsule glass bottle and jar platform.
DERMIS//01 is a full-concept packaging development project by Jarsking — a working demonstration of how a science-led skincare brand can be conceived, structured, and packaged as a coherent, retail-ready clinical system, from brand philosophy to bottle specification to social-content deployment. Every element shown here — the pharmaceutical-capsule silhouette, the frosted-glass-and-graphite material story, the five-step product hierarchy, the gift-set architecture — was developed on Jarsking’s own glass capsule platform, with real manufacturing logic behind every creative decision.
The concept answers a measurable market shift. The global cosmeceuticals market is estimated at roughly USD 80–100 billion in 2025, and the doctor-recommended, clinically-positioned tier is one of its fastest-growing segments at close to 9% CAGR — driven by consumers who cross-reference product claims with dermatology research before they buy. DERMIS//01 packages that buyer’s worldview: precision, evidence, restraint.
The name does the first layer of work before a single ingredient is read. Dermis is the correct anatomical term for the skin’s primary functional layer; 01 signals a system designed with sequenced, numbered logic rather than aesthetic whim. Together they communicate medical legitimacy at a glance — the exact cue the modern skincare buyer is scanning for.
That buyer is real and well-documented. They read the clinical study before the serum, know the difference between AHA and BHA, and will invest USD 80+ in a single product when the formulation logic holds — but they are resistant to gimmick packaging and respond to transparency, precision, and restraint. The packaging system is engineered for exactly this reader: every panel rewards close inspection, and nothing shouts. For a brand, that is not a mood — it is a conversion strategy aimed at a high-intent, high-LTV customer.
Positioning is a packaging brief, not a slogan. DERMIS//01 sits at the accessible clinical-premium tier — benchmarked against Medik8, SkinCeuticals, Paula’s Choice, Dr. Barbara Sturm, and Augustinus Bader — and targets two buyers at once: the Informed Optimizer (28–45, urban, data-literate, DTC-first) and the Clinic-Referred Patient (35–60, sent home after a laser, peel, or injectable to protect a clinical investment).
Both buyers reward a medical visual code and punish theatrical beauty packaging. So the design system removes warmth from the typography and the surface, and relocates it to two places only: the graphite cap and the formula color seen through frosted glass. The result reads as a lab instrument that happens to be beautiful — credibility first, desire second. That sequence is what lets a clinical brand command premium price and earn the clinic channel’s trust.
The structural backbone of the concept is the Jarsking oblong capsule glass bottle. Its silhouette is not incidentally clinical — it is the exact form of a pharmaceutical capsule rendered at industrial scale. In frosted, thick-base glass with a warm-graphite injection-molded cap, it reads simultaneously as a laboratory instrument and a luxury object.
The horizontal ribbing on the capsule body becomes a proprietary brand asset. Read in a clinical-imaging context, the ribs scan as ultrasound lines, MRI cross-sections, or the grid of a dermatoscope — referenced in the brand’s visual language as “frequency lines,” the structural frequency at which the skin is being corrected. A distinctive, ownable silhouette is a commercial advantage: it is recognizable on a shelf, in a 200-pixel thumbnail, and in a competitor-crowded search result.
The art direction strips out color distraction and leaves a stark interplay of bone-white and cool-gray, viewed as if through X-ray vision: an empty laboratory bench, surgical steel, electron-microscope texture, molecular bond line-art, pharmaceutical grid paper. The discipline is the point. A single, tightly defined visual register makes every downstream asset — PDP, flat-lay, story frame, retail display — look like it belongs to one system.
There is a hard commercial dividend to that consistency. In social-led skincare, packaging is the product’s first advertisement, and a coherent visual identity dramatically lowers the cost and time of producing on-brand content at volume.
| Element | Color | Finish |
|---|---|---|
| Glass body | Frosted clear | Acid-etch or sand-blast texture |
| Pump cap / jar cap | Warm graphite | Matte rubber-touch injection |
| Silk-screen print | Bone white or cool platinum | Single color, 2 colors maximum |
| Step numbers | Bone white, 3× tracking | Ultra-legible on frosted glass |
| Formula color (through glass) | Varies by SKU | Natural, unpigmented |
The palette is deliberately mono: a graphite-and-bone system with no decorative warmth.
Five SKUs, graduated across four bottle heights and one jar, create a compact, complete skin system that displays with architectural coherence — on a bathroom shelf, a clinic counter, or a DTC landing-page flat-lay.
| Step | Product | Size | Format | Cap | Function |
|---|---|---|---|---|---|
| 01 | DERMIS//01 CLEANSE | 100 ml | Capsule bottle + lotion pump | Warm graphite matte | Microbiome-balanced gel cleanser |
| 02 | DERMIS//01 ACTIVATE | 120 ml | Capsule bottle + lotion pump | Warm graphite matte | Multi-acid resurfacing toner (AHA·BHA·PHA) |
| 03 | DERMIS//01 SIGNAL | 30 ml | Capsule bottle + lotion pump | Warm graphite matte | Peptide & growth-factor serum |
| 04 | DERMIS//01 BARRIER | 50 ml | Capsule bottle + lotion pump | Warm graphite matte | Ceramide & lipid restoration emulsion |
| 05 | DERMIS//01 SHIELD | 50 g | Capsule jar + screw cap | Warm graphite matte | Mineral SPF 50 PA++++ finishing cream |
Selling a sequenced protocol rather than five separate products is a deliberate commercial play: a system raises average order value, builds a built-in repurchase ladder, and turns the full lineup into a single, photogenic brand object.
The capsule bottle is the commercial centerpiece. Its frosted, thick-base glass shields light-sensitive acids and peptides, while the format is engineered to pair with precision lotion-pump dispensing
SPF is the product most likely to drive daily, habitual repurchase, and it is the clearest signal that DERMIS//01 is a complete morning-to-night clinical system rather than a loose collection of treatments.
The category tailwind is strong: the mineral sunscreen market sits near USD 4.85 billion in 2025 and is forecast to grow at roughly 13% CAGR, with SPF 50+ the fastest-growing sub-segment as “clean” and reef-safe sun care goes mainstream. The foil-sachet format shown here is a sampling and trial-conversion tool — a low-cost way to seed the hero SKU into gift-with-purchase, clinic hand-outs, and travel kits, then convert trial into the full-size jar.
Texture decides dispensing, and dispensing decides packaging. Each DERMIS//01 format is chosen to protect the formula’s performance and the user’s experience: a lotion pump meters the microbiome gel cleanser and the lipid emulsion without waste; a low-dose pump delivers the 30 ml peptide serum drop-accurate; a wide-mouth jar suits the mineral SPF cream’s richer, scoop-and-seal texture. When the container is matched to the rheology of what’s inside, the formula performs as formulated and the ritual feels considered rather than fiddly — a quiet driver of repurchase.
When a brand sells a sequenced routine instead of a single SKU, two things happen: average order value rises, and the customer is structurally guided toward replenishing the whole set rather than one piece. The tray’s molded insert seats each capsule in step order (01→05), so the first experience a buyer has — opening the box — already teaches the ritual.
The gift-box concept can be developed across rigid-board construction with deboss, foil-stamp, or screen-print branding; custom tray inserts in multiple colorways; and magnetic-closure or ribbon-pull formats. Structural prototyping and material selection are supported alongside primary-packaging development — one partner, one contact, from bottle to box.
This is where packaging earns its second job. In content-driven e-commerce, the bottle is the first ad the customer ever sees, and a system engineered to photograph above its production cost compounds every media dollar.
It is also a K-beauty–era advantage: Korea became the No. 2 cosmetics exporter globally in Q1 2025 and overtook France as the top exporter to the U.S., with U.S. K-beauty demand up ~53% year-over-year — a market that rewards exactly this science-forward, visually-disciplined register.
The range is built for a high-intent clinical buyer and a multi-channel rollout:
| Channel | Markets | Hero SKUs |
|---|---|---|
| DTC brand site | US / UK / AU | Full 5-piece set + “Protocol Starter” bundle |
| Dermatology-clinic retail | US / UK / DE | SIGNAL 30 ml + BARRIER 50 ml (post-treatment pair) |
| Sephora / Space NK | US / UK | ACTIVATE 120 ml + CLEANSE 100 ml (hero duo) |
| Amazon Premium Beauty | US | SHIELD 50 g SPF (standalone entry SKU) |
| Tmall International / Xiaohongshu | China | Full set; SIGNAL as KOL hero |
| Travel retail & gifting | Pan-market | Protocol Starter Mini; full set in rigid box |
Because the same five SKUs flex across DTC, clinic, prestige retail, and social commerce, the packaging system has to hold up under medical scrutiny and in a thumbnail. DERMIS//01 is designed to do both — which is what makes a clinical range scalable across markets rather than locked to one.
17th Floor, East Tower, Building 2,
Yiyun Tech Innovation Center,
No. 33-13, Jinshi Third Road, Dayuan Street,
Baiyun District, Guangzhou City,
Guangdong Province, China
Office 10, 24th Floor,
The One Tower,
943 Sheikh Zayed Road,
Barsha Heights (Al Thanyah First),
Dubai, United Arab Emirates
© Copyright 2026 Jarsking Packaging All Rights Reserved.
